Dr. Axelrad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
305 East 33rd Street
New York, NY 10016- Is this information wrong?
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Gastroenterology, 2015 - 2018
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2012 - 2015
- Tufts University School of MedicineClass of 2012
Certifications & Licensure
- FL State Medical License 2022 - 2026
- NY State Medical License 2013 - 2024
- CT State Medical License 2022 - 2024
- PA State Medical License 2022 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- Outcomes after Fecal Microbiota Transplantation in combination with Bezlotoxumab for Inflammatory Bowel Disease and Recurrent C . difficile Infection.Jessica R Allegretti, Jordan Axelrad, Rahul S Dalal, Colleen R Kelly, Ari Grinspan, Monika Fischer> ;The American Journal of Gastroenterology. 2024 Mar 19
- The Management of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease.Jordan E Axelrad, David T Rubin> ;Clinical Gastroenterology and Hepatology. 2024 Feb 29
- Upadacitinib as Rescue Therapy for the Treatment of Acute Severe Colitis in an Acute Care Setting.Joseph Clinton, Kiran K Motwani, Stephen Schwartz, Patrick McCarthy, Jordan E Axelrad, Raymond K Cross, Lauren George> ;Digestive Diseases and Sciences. 2024 Feb 28
- Join now to see all
Journal Articles
- A Novel Method for Quantifying Intestinal Inflammatory Burden in Inflammatory Bowel Disease Using Register DataJordan Axelrad, MD, Dove Press
- Enteric Infections Are Common in Patients with Flares of Inflammatory Bowel DiseaseAndrew Joelson, Simon Lichtiger, Jordan E Axelrad, Garrett Lawlor, Benjamin Lebwohl, Nature
Abstracts/Posters
- Patients with Inflammatory Bowel Disease and a history of cancer: The risk of cancer following exposure to immunosuppressionAxelrad J, Bernheim O, Colombel JF, Malerba S, Ananthakrishnan A, Yajnik V, Hoffman G, Agrawal M, Lukin D, Desai A, Mceachern E, Bosworth B, Scherl E, Reyes A, Zaidi H..., European Crohn's and Colitis Organisation Congress 2015, Barcelona, Spain, 2/20/2015
- The risk of incident cancer in patients with Inflammatory Bowel Disease and a history of cancer following immunosuppression exposureAxelrad J, Bernheim O, Colombel JF, Anathakrishnan A, Yajnik V, Katz S, Malerba S, Itzkowitz S, 2014 Advances in Inflammatory Bowel Diseases, Crohn’s & Colitis Foundation’s Clinical & Research Conference, Orlando, Florida, 12/3/2014
- Clostridium difficile Infection in Inflammatory Bowel Disease: A Nursing Based Quality Improvement StrategyAxelrad JE, Shah BJ, American College of Gastroenterology annual scientific meeting, Philadelphia, Pennsylvania, 10/21/2014
- Join now to see all
Authored Content
- AIBD 2022: Cancer in Patients With Inflammatory Bowel DiseaseDecember 2022
Press Mentions
- AGA Guideline Defines Role of Biomarkers in Ulcerative ColitisFebruary 25th, 2023
- IBD Linked to Growing Number of Inflammation-Related DiseasesApril 11th, 2019
- Non-C. Diff Infections Common in IBD FlaresAugust 11th, 2018
Professional Memberships
- Member
- Member
- Member
- Crohn's and Colitis FoundationMember
Hospital Affiliations
- NYU Langone HospitalsNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: